Wang Shanshan, Liu Yanqing, Hu Liqing, Qian Guoqing, Mo Yijun
Department of Laboratory Medicine, The First Affiliated Hospital of Ningbo University, Ningbo, China.
Department of Infectious Diseases, The First Affiliated Hospital of Ningbo University, Ningbo, China.
Front Med (Lausanne). 2025 Apr 9;12:1544621. doi: 10.3389/fmed.2025.1544621. eCollection 2025.
We report a rare case of pulmonary mucormycosis caused by , which is rare in patients with chronic obstructive pulmonary disease. had been reported as the most common etiological agent associated with human infections, except in some studies.
We described a case of 81-year-old man with pulmonary mucormycosis caused by but no other apparent risk factors including diabetes. The diagnosis mainly relied on sputum cultures and clinical manifestations. Despite antifungal therapy, his condition worsened, resulting in mortality.
In this case, the patient had no underlying diseases such as diabetes or solid tumors. Clinicians should be aware of routine pathogenic microbiological tests of pulmonary mucormycosis in patients with chronic obstructive pulmonary disease. Early and aggressive treatment can lead to improved prognosis.
我们报告了一例罕见的由 引起的肺毛霉菌病病例,该病例在慢性阻塞性肺疾病患者中较为罕见。除了在一些研究中 外, 已被报道为与人类感染相关的最常见病原体。
我们描述了一例81岁男性肺毛霉菌病病例,该病例由 引起,但无其他明显危险因素,包括糖尿病。诊断主要依靠痰培养和临床表现。尽管进行了抗真菌治疗,但其病情仍恶化,最终导致死亡。
在本病例中,患者无糖尿病或实体瘤等基础疾病。临床医生应注意对慢性阻塞性肺疾病患者进行肺毛霉菌病的常规病原微生物检测。早期积极治疗可改善预后。